×
Volver a Agenda
Session Chair(s)
Richard Alan Brook, MBA, MS
Head, Retrospective Analysis
The Jestarx Group, United States
Learning Objective : Define comparative effectiveness research (CER) and evidence-based medicine (EBM) terminology; Describe how the health care environment is creating the opportunity to better use CER and EBM; Identify managed care executives’ perceptions on CER and EBM use in coverage decision making today and in the future.
Speaker(s)
Medical and Pharmacy Directors' Views on CER and EBM
Richard Alan Brook, MBA, MS
The Jestarx Group, United States
Head, Retrospective Analysis
A Pharmaceutical Company's Perspective on CER and EBM
Kitty Rajagopalan, PHD, MS
Sunovion Pharmaceuticals Inc., United States
Vice President, Health Economics and Outcomes Research
Making CER and EBM Results Actionable: The Perspective of an Independent Evidence Review Organization
Daniel A. Ollendorf, PHD, MPH
Center for the Evaluation of Value and Risk in Health, United States
Director, Value Measurement & Global Health Initiatives
¿Tiene una cuenta?